Overview
Employees
1-10
Total raised
$3.6M
Founded date
2006
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 22, 2016 | Mucosis brings in $4M for development of first RSV vaccine | Mucosis isn’t the only one looking to develop a RSV vaccine, but they do have an innovative approach. CEO Tom Johnston shared in an interview about the company’s current progress and how their vaccine differs from other potential options. H... |
| Jun 4, 2010 | Mucosis Receives €3M Credit Line from Agentschap NL for FluGEM Program | Mucosis B.V., a Groningen, The Netherlands-based vaccine development company developing innovative mucosal vaccines that can be applied needle-free via the nose or mouth, has received an innovation credit line of approximately €3m from Agen... |
| Mucosis brings in $4M for development of first RSV vaccine | Dutch biotech company, Mucosis, announced on Wednesday that it secured a $4 million fund awarded from the Wellcome Trust foundation. This will go toward clinical trials – a phase I dose-finding and safety study, followed by a novel phase II... |
Reviews 0
FAQ about combell.nl Parkpage
When was combell.nl Parkpage founded?
combell.nl Parkpage was founded in 2006.
How much funding has combell.nl Parkpage raised?
combell.nl Parkpage has raised $3.6M in total across 1 funding round.
What has the press written about combell.nl Parkpage?
Parsers VC has collected 4 articles mentioning combell.nl Parkpage, among them “Mucosis brings in $4M for development of first RSV vaccine” (Jan 22, 2016) and “Mucosis Receives €3M Credit Line from Agentschap NL for FluGEM Program” (Jun 4, 2010).
Is combell.nl Parkpage still active?
Yes, combell.nl Parkpage is active; its latest activity on Parsers VC dates from Jan 25, 2016.